Carl Zeiss Meditec AG Profile Avatar - Palmy Investing

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and …

Medical - Instruments & Supplies
DE, Jena [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 100.00 2.13 0.00
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 550.99 1.66 0.26
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 100.00 22.92 0.00
Cash 32.24 0.23 0.17
Capex 0.00 0.00 0.00
Free Cash Flow 1236.94 0.42 -0.03
Revenue 7.47 6.46 6.01
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -8.01 0.50 0.54
Operating Margin inf 0.00 0.10
ROA 100.00 0.02 0.00
ROE 83.64 0.03 0.02
ROIC inf 0.00 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CZMWY is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CZMWY is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CZMWY is permitted for members.